Latest filing published 03 Apr 2008 for ENCYSIVE PHARMACEUTICALS INC, €52k.
No signal scores available.
James T. Willerson appears in our data through filings on Encysive Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 13 filings cover trades dated from 31 December 2005 to 1 April 2008.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 April 2008 came the latest disclosure, a transaction for €24k in Encysive Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations